Caci International INC /DE/ Form 4 insider transactions

CACI International Director Ryan D. McCarthy reported the vesting of 84 Restricted Stock Units into common stock on January 14, 2026.

CACI International Director William L. Jews sold 3,000 shares of common stock for $585.82 per share, reducing his direct beneficial ownership to 3,384 shares, as part of a pre-arranged 10b5-1 plan.

CACI's Chief Financial Officer, Jeffrey D. MacLauchlan, increased his direct ownership of company stock through the vesting of restricted stock units and performance-based awards, with performance targets notably exceeded.

CACI International Director Scott C. Morrison received a grant of 338 Restricted Stock Units, vesting quarterly through October 2026.

CACI International's SVP, Corporate Controller & CAO, Eric Blazer, reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

CACI International Director William L. Jews received a grant of 338 Restricted Stock Units, vesting quarterly through October 2026.

CACI International Inc. director Debora A. Plunkett was granted 338 Restricted Stock Units, vesting over approximately one year.

CACI International Inc. director Susan M. Gordon received a grant of 338 Restricted Stock Units, vesting quarterly through October 2026.

CACI International Director Philip O. Nolan received a grant of 338 Restricted Stock Units, vesting over approximately one year.

CACI International Inc. Director Lisa S. Disbrow reported an acquisition of common stock and Restricted Stock Units as part of her annual compensation.

CACI International Director Stanton D. Sloane received a grant of 338 Restricted Stock Units, vesting quarterly through October 2026.

CACI International Inc. Director Charles L. Szews received a grant of 338 Restricted Stock Units, vesting quarterly through October 2026.

CACI International Director Ryan D. McCarthy received a grant of 338 Restricted Stock Units, vesting quarterly through October 2026.

CACI International Director Philip O. Nolan acquired 83 shares of common stock on October 12, 2025, through the scheduled vesting of Restricted Stock Units.

CACI International Director Stanton D. Sloane exercised 83 Restricted Stock Units, converting them into common stock and increasing his direct beneficial ownership to 859 shares.

CACI International Director Debora A. Plunkett acquired 83 shares of common stock through the vesting of Restricted Stock Units.

CACI International Director Ryan D. McCarthy acquired 83 shares of common stock through the scheduled vesting of Restricted Stock Units.

CACI International Director Scott C. Morrison converted 83 Restricted Stock Units into common stock, completing the vesting of a 331-unit grant.

CACI International Director William L. Jews acquired 83 common shares through the vesting of Restricted Stock Units, increasing his direct beneficial ownership.

CACI International Director Charles L. Szews reported the vesting of 83 Restricted Stock Units into common stock, completing a 331-unit grant.

CACI Director Lisa Disbrow acquired 83 shares of common stock through the vesting of Restricted Stock Units, increasing her direct beneficial ownership to 1,934 shares.

CACI International Director Susan M. Gordon acquired 83 shares of common stock through the vesting of Restricted Stock Units, increasing her direct beneficial ownership to 2,737 shares.

CACI International's Chief Financial Officer, Jeffrey D. MacLauchlan, reported the vesting of restricted stock units and new equity grants on October 1, 2025.

CACI International CEO John S. Mengucci reported the future vesting and acquisition of common stock, along with new RSU and PRSU grants, effective October 1, 2025.

CACI International's President of US Operations, DeEtte Gray, reported multiple stock acquisitions through vesting and dispositions for tax withholding purposes.

CACI International Inc's Chief Executive Officer, UK, Tracy Weir, reported routine stock acquisitions and dispositions related to equity compensation vesting.

CACI International's EVP and General Counsel, J. William Koegel Jr., reported the vesting of restricted stock units and new equity grants on October 1, 2025.

CACI International's SVP, Corporate Controller & CAO, Eric Blazer, reported recent equity transactions including RSU and PRSU grants, and common stock activity.

CACI International's President and CEO, John S. Mengucci, sold 10,175 shares of common stock for approximately $5 million as part of a pre-arranged 10b5-1 trading plan.

Tracy Weir, CACI International's Chief Executive Officer for the UK, converted 268 restricted stock units into common stock following their vesting on August 22, 2025.